Literature DB >> 33562759

Epidemiological Impact of Myocarditis.

Ainoosh Golpour1, Dimitri Patriki2, Paul J Hanson3, Bruce McManus3, Bettina Heidecker1.   

Abstract

Myocarditis is an inflammatory disease of the heart muscle with a wide range of potential etiological factors and consequently varying clinical patterns across the world. In this review, we address the epidemiology of myocarditis. Myocarditis was considered a rare disease until intensified research efforts in recent decades revealed its true epidemiological importance. While it remains a challenge to determine the true prevalence of myocarditis, studies are underway to obtain better approximations of the proportions of this disease. Nowadays, the prevalence of myocarditis has been reported from 10.2 to 105.6 per 100,000 worldwide, and its annual occurrence is estimated at about 1.8 million cases. This wide range of reported cases reflects the uncertainty surrounding the true prevalence and a potential underdiagnosis of this disease. Since myocarditis continues to be a significant public health issue, particularly in young adults in whom myocarditis is among the most common causes of sudden cardiac death, improved diagnostic and therapeutic procedures are necessary. This manuscript aims to summarize the current knowledge on the epidemiology of myocarditis, new diagnostic approaches and the current epidemiological impact of the COVID-19 pandemic.

Entities:  

Keywords:  diagnosis; epidemiology; etiology; incidence and prevalence; myocarditis; myocarditis associated with COVID-19; regional differences

Year:  2021        PMID: 33562759      PMCID: PMC7915005          DOI: 10.3390/jcm10040603

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  158 in total

1.  Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.

Authors:  Thomas M Maddox; P Michael Ho; Matthew Roe; David Dai; Thomas T Tsai; John S Rumsfeld
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-05

2.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

3.  Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

Authors:  J C Chang; R Xiao; L Mercer-Rosa; A M Knight; P F Weiss
Journal:  Lupus       Date:  2018-10-14       Impact factor: 2.911

4.  Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS.

Authors:  A M Sartori; M H Lopes; B Caramelli; M I Duarte; P L Pinto; V Neto; M Amato Shikanai-Yasuda
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

5.  Electrocardiographic pattern in children suffering from typhoid fever.

Authors:  A Salaki; M P Samik Wahab; B Sugeng
Journal:  Paediatr Indones       Date:  1985 Jul-Aug

6.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

7.  Lyme borreliosis as a cause of myocarditis and heart muscle disease.

Authors:  J Klein; G Stanek; R Bittner; R Horvat; C Holzinger; D Glogar
Journal:  Eur Heart J       Date:  1991-08       Impact factor: 29.983

8.  Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy.

Authors:  M Grogan; M M Redfield; K R Bailey; G S Reeder; B J Gersh; W D Edwards; R J Rodeheffer
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

9.  How does age at onset influence the outcome of autoimmune diseases?

Authors:  Manuel J Amador-Patarroyo; Alberto Rodriguez-Rodriguez; Gladis Montoya-Ortiz
Journal:  Autoimmune Dis       Date:  2011-12-13

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  10 in total

1.  A Rare Case of Myocarditis After the First Dose of Moderna Vaccine in a Patient With Two Previous COVID-19 Infections.

Authors:  Aniekeme S Etuk; Inimfon N Jackson; Hercules Panayiotou
Journal:  Cureus       Date:  2022-05-07

2.  Clinical course, viral etiology, and the diagnostic workup for patients with suspected myocarditis: a single-center prospective study.

Authors:  Shimaa S Khidr; Mohamed Ahmed El-Mokhtar; Shery Refaat Asaad; Helal F Hetta; Mona Hussein Abdel-Rahim; Amr Ahmed Aly Youssef; Ayman K M Hassan
Journal:  BMC Cardiovasc Disord       Date:  2022-09-06       Impact factor: 2.174

Review 3.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

4.  Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination.

Authors:  Samantha Lane; Alison Yeomans; Saad Shakir
Journal:  BMJ Open       Date:  2022-07-01       Impact factor: 3.006

5.  Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.

Authors:  Samantha Lane; Alison Yeomans; Saad Shakir
Journal:  BMJ Open       Date:  2022-05-25       Impact factor: 3.006

6.  Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.

Authors:  Natalia Abraham; Sarah Spruin; Tanya Rossi; Bruce Fireman; Joseline Zafack; Christine Blaser; Amanda Shaw; Kimberley Hutchings; Susanna Ogunnaike-Cooke
Journal:  Vaccine       Date:  2022-05-25       Impact factor: 4.169

7.  Evaluation of histopathological findings of cardiac deaths in forensic autopsies.

Authors:  Taner Daş; Aytül Buğra; Abdul Kerim Buğra
Journal:  Ir J Med Sci       Date:  2021-05-10       Impact factor: 1.568

8.  Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients.

Authors:  Caterina Beatrice Monti; Francesco Secchi; Marco Alì; Francesco Saverio Carbone; Luca Bonomo; Davide Capra; Nazanin Mobini; Giovanni Di Leo; Francesco Sardanelli
Journal:  Tomography       Date:  2022-04-01

9.  Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus.

Authors:  Abire Allaoui; Amal El Ouarradi; Rajaa Jabbouri; Abdelhamid Naitelhou
Journal:  Cureus       Date:  2022-06-09

10.  A Comparative Analysis of COVID-19 Vaccines Based on over 580,000 Cases from the Vaccination Adverse Event Reporting System.

Authors:  Kathleen Gallo; Andrean Goede; Cameron Mura; Renata Abel; Barbara Moahamed; Saskia Preissner; Susanne Nahles; Max Heiland; Philip E Bourne; Robert Preissner; Michael Mallach
Journal:  Vaccines (Basel)       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.